Description
Pulsed electromagnetic fields (iOne®, IGEA S.p.A, Italy) effectiveness in inflammation modulation and articular homeostasis promotion has been widely demonstrated in in- vitro and in-vivo on animal models research.
The primary goal of this study was to evaluate the effectiveness of iOne® in reducing post-operative pain (measured by VAS score) after anterior cruciate ligament (ACL) reconstruction associated with tibial and femoral bone bruise (BB) when applied at least for 4 hours a day, 15 days before and 2 months after surgery.
Secondary goals were quantification of the BB area dimensional reduction (measured by WORMS scale), improvement in knee functional outcomes (measures by IKDC, KOOS and TEGNER scores), and global health condition (measured by SF-12 score).